2seventy bio, Inc.·4

Mar 9, 9:48 PM ET

Wei Lin 4

4 · 2seventy bio, Inc. · Filed Mar 9, 2023

Insider Transaction Report

Form 4
Period: 2023-03-07
Wei Lin
Director
Transactions
  • Award

    Stock Option (Right to buy)

    2023-03-07+33,40033,400 total
    Exercise: $10.91Exp: 2033-03-07Common Stock (33,400 underlying)
  • Award

    Common Stock

    2023-03-07+16,60016,600 total
Footnotes (2)
  • [F1]This restricted stock unit award vests ratably over three years in annual installments with the first installment vesting on March 7, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
  • [F2]This stock option vests ratably over three years in annual installments with the first installment vesting on March 7, 2024, subject to the Reporting Person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT